Hepatitis B prevalence nears 10% in Nioro du Rip, Senegal

Hepatitis B prevalence in the Nioro du Rip department of Senegal has reached approximately 10%, according to Dr. Ousseynou Cissé, the district's chief medical officer. This figure aligns with the national prevalence range in Senegal, which fluctuates between 5.7% and 10% for chronic carriers.

Dr. Cissé noted that prevalence is highest among individuals born before the introduction of systematic newborn vaccination, while younger, vaccinated generations show a declining trend. However, medical professionals face significant challenges in managing the disease due to a lack of technical resources. Specifically, the department lacks equipment for viral load testing and FibroScan devices to assess liver health. There are also reported difficulties in the consistent supply of Tenofovir, an essential antiviral medication.

To meet Senegal's goal of eliminating viral hepatitis B and C by 2030, Dr. Cissé is calling for strengthened technical platforms and the decentralization of diagnostic and care services to rural health posts. Additionally, given Nioro's proximity to the border, he has advocated for improved coordination and harmonized health interventions between Senegal and the Gambia.